Skip to Content

Division of Pediatrics - Division Priority List

MD Anderson

Pediatric Clinical Trials

  

Disease Type Phase / Type Title Physician Contact / Phone Protocol Number
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Acute Lymphoblastic Leukemia (ALL)
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Acute Myelogenous Leukemia (AML)
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)
   II Thiotepa-Clofarabine-Busulfan with Allogeneic and Haploidentical Stem Cell Transplant for High Risk Malignancies Worth, Laura L., M.D., Ph.D. Woodworth, Glenda G., R.N.
(713) 795-2058
2008-0363
   II Busulfan-Fludarabine-Clofarabine with allogeneic stem cell transplantation for advanced refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome and advanced, Gleevec refractory Chronic Myeloid Leukemia. A Randomized Phase II Study Champlin, Richard E., M.D. Main Switchboard
(713) 792-6161
2006-0200
   I/II Cord Blood Expansion on Mesenchymal Stem Cells Shpall, Elizabeth, M.D. Main Switchboard
(713) 792-6161
2005-0781
   I/II Alloreactive NK Cells with Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplantation for AML and MDS Champlin, Richard E., M.D. Main Switchboard
(713) 792-6161
2005-0508
   I Delayed Infusion of Ex Vivo Anergized Peripheral Blood Mononuclear Cells Following CD34 Selected Peripheral Blood Stem Cell Transplant From A Haploidentical Donor For Patients With Acute Leukemia and Myelodysplasia de Lima, Marcos, M.D. Main Switchboard
(713) 792-6161
2005-0695
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Aplastic Anemia
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Brainstem Glioma/ Pontine Glioma
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Central Nervous System (CNS)
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Central Nervous System/Brain Tumors
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Chronic Lymphocytic Leukemia
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Chronic Myeloid Leukemia (CML)
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Ependymoma
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Hodgkin's Disease
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Laboratory
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Medulloblastoma/Primitive Neuroectodermal Tumors (PNET)/Embryonal Tumors
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Non-Hodgkin's Lymphoma
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Other
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Other, Blood/BM Collection
cell therapy (bone marrow transplantation) - Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)  Pediatric Tumors/Conditions